top of page
Browse by category
Search
12% of Americans have used GLP-1 weight loss drugs
Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to report from...
Ozempic may weaken muscles even as muscle size remains stable
A study in mice by researchers at the University of Utah Health Sciences suggests that muscle mass changes less than expected, but...
Innovent receives FDA Approval for IND application of oral GLP-1R agonist IBI3032
Innovent Biologics has announced the FDA has approved the investigational new drug (IND) application to initiate a Phase 1 clinical trial...
Allurion to increase focus on low-dose GLP-1 combination therapy and muscle mass maintenance
Allurion Technologies has revealed a strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass...
Journal Watch 6/8/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
NICE: People need support to keep weight off after treatment ends
The National Institute for Health and Care Excellence in the UK has stated that people coming off obesity medication or finishing a...
Browse by tag
bottom of page